Skip to content
Register Sign in Wishlist

The Clozapine Handbook
Stahl's Handbooks

$49.99 (G)

Part of Stahl's Essential Psychopharmacology Handbooks

  • Date Published: May 2019
  • availability: In stock
  • format: Paperback
  • isbn: 9781108447461
Average user rating
(1 review)

$ 49.99 (G)
Paperback

Add to cart Add to wishlist

Other available formats:
eBook


Looking for an examination copy?

If you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact collegesales@cambridge.org providing details of the course you are teaching.

Description
Product filter button
Description
Contents
Resources
Courses
About the Authors
  • Real-world and clinical trial data support that clozapine is the only effective antipsychotic for treatment resistant schizophrenia and other severe mental illnesses. Clozapine also reduces rates of suicidality, psychiatric hospitalization and all-cause mortality. However, clozapine is underutilized for two reasons: misunderstandings of its efficacy benefits and misapprehension of, limited knowledge or misinformation about the management of treatment related risks and adverse effects. In response to worldwide efforts to promote clozapine use, this user-friendly Handbook provides clinicians with evidence-based approaches for patient management as well as logical approaches to the management of clinical situations and adverse effects. It outlines clearly the rationale for specific management decisions and prioritises the options based on this logic. This Handbook is designed for use by clinicians worldwide and is essential reading for all mental health care professionals.

    • The increased interest in promoting greater clozapine use internationally means this book fills a gap in the market for clinicians who seek evidence-based advice on best practices
    • Use of clozapine has shown real world benefits such as a reduction in suicidality, psychiatric hospitalization and mortality rates. Many clinicians are unfamiliar with recent improvements in the understanding of clozapine-related dosing and adverse effect management
    • Provides a logical, evidence-based framework for important clinical issues - this handbook leads the clinician through the reasoning process for adverse effect management and other common clinical situations
    Read more

    Customer reviews

    24th May 2019 by ESchwartz

    The Clozapine Handbook is a super useful reference that can give any psychiatrist the expertise they need to to prescribe clozapine confidently. The book provides a high level of clinically relevant information that is not provided in most psychiatric residencies. This handbook is now the most up-to-date and clinically relevant clozapine reference in the world. There is nothing else like it. The book is well-indexed so it is very easy to locate specific information on just about any topic related to clozapine. There are helpful tables, graphs and summary boxes. The book contains everything from the history of clozapine, how to initiate and titrate clozapine, what you need to know about clozapine metabolism and drug interactions, how to monitor clozapine plasma levels, how to monitor for potential adverse side effects and how to effectively manage bothersome side effects to keep your patients on clozapine like a world class psychopharmacologist!

    Review was not posted due to profanity

    ×

    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?

    ×

    Product details

    • Date Published: May 2019
    • format: Paperback
    • isbn: 9781108447461
    • length: 326 pages
    • dimensions: 186 x 123 x 14 mm
    • weight: 0.36kg
    • contains: 24 b/w illus.
    • availability: In stock
  • Table of Contents

    Preface
    1. Initiating Clozapine
    2. Understanding hematologic monitoring and benign ethnic neutropenia
    3. Binding profile, metabolism, kinetics, drug interactions and use of plasma levels
    4. Managing constipation
    5. Managing sialorrhea
    6. Managing sedation, orthostasis and tachycardia
    7. Managing metabolic adverse effects
    8. Managing seizure risk and stuttering
    9. Fever, myocarditis, interstitial nephritis, DRESS, serositis and cardiomyopathy
    10. Eosinophilia, leukocytosis, thrombocytopenia, thrombocytosis, anemia, hepatic function abnormalities
    11. Managing enuresis and incontinence, priapism, venous thromboembolism, neuroleptic malignant syndrome, tardive dyskinesia and obsessive compulsive disorder
    12. The efficacy story: treatment resistant schizophrenia, psychogenic polydipsia, treatment intolerant schizophrenia, suicidality, violence, mania and Parkinson's disease psychosis
    13. Addressing clozapine positive symptom nonresponse in schizophrenia spectrum patients
    14. Discontinuing clozapine and management of cholinergic rebound
    15. Special topics: child and adolescent patients, elderly patients, patients with intellectual disability, pregnancy and risk for major congenital malformation, lactation, overdose, postmortem redistribution
    Index.

  • Authors

    Jonathan M. Meyer, University of California, San Diego
    Jonathan M. Meyer is currently a Clinical Professor of Psychiatry at the University of California, San Diego and a Psychopharmacology Consultant to the California Department of State Hospitals. Dr Meyer is an internationally recognised speaker on psychopharmacology and the treatment of severe mental illness, and is Distinguished Fellow of the American Psychiatric Association.

    Stephen M. Stahl, University of California, San Diego
    Stephen M. Stahl is currently a Professor at the University of California, San Diego and serves as Honorary Fellow in the psychiatry department at the University of Cambridge. He is also the Chairman of the Neuroscience Education Institute (NEI) and Arbor Scientia Group. Dr Stahl serves as the Director of Psychopharmacology Services at the California Department of State Hospitals as well as the Editor-in Chief of CNS Spectrums.

Sign In

Please sign in to access your account

Cancel

Not already registered? Create an account now. ×

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email lecturers@cambridge.org

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×

Find content that relates to you

Join us online

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.

Cancel

Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

×
Please fill in the required fields in your feedback submission.
×